In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader (regular type). The authors' commentary follows.
The patient's immunosuppressive regimen increases her risk for the development of chronic pneumonia. Reactivation of previously acquired tuberculosis or endemic fungi such as Histoplasma capsulatum or Blastomyces dermatitidis may have occurred. Alternatively, she may have acquired a pulmonary infection with an atypical mycobacteria or pathogens such as Pneumocystis jiroveci, Rhodococcus equi, or nocardia species. Giantcell arteritis can occasionally result in chronic cough, but this is uncommon. Because of her negative temporal-artery biopsy, it is possible that the patient's earlier symptoms reflected an alternative cause of vasculitis that might now have affected the lungs (e.g., Wegener's granulomatosis). Other possible noninfectious causes of her clinical presentation include bronchiolitis obliterans with organizing pneumonia and eosinophilic pneumonia; however, the fact that symptoms developed while she was taking considerable doses of prednisone reduces the likelihood of these two possibilities, because of their responsiveness to corticosteroids.
The patient had a history of T2N0 adenocarcinoma of the right lung (according to the tumor-node-metastasis classification system), which had been treated with lobectomy of the right upper lobe 6 years earlier. 
mg per deciliter). A chest radiograph revealed air-space opacity in the left upper lobe (Fig. 1).
It is likely that the patient's lymphopenia is secondary to her immunosuppressive medications. Her high erythrocyte sedimentation rate at this time most likely reflects infection, but a recurrence of rheumatic disease or cancer could also contribute to this finding. Reactivation tuberculosis does have a predilection for the upper lobes, but there is considerable overlap in radiographic presentation in the pathogens mentioned thus far, particularly in immunosuppressed patients. Regardless, given her history, active pulmonary tuberculosis should be ruled out by three sputum smears for acid-fast bacilli. Acid-fast staining and culture of bronchoalveolar-lavage fluid may also be needed. At this point, I would obtain computed tomography (CT) of the lungs to better characterize the lesion and evaluate for lymphadenopathy.
The patient was admitted to the hospital and was given cefepime and ciprofloxacin. Blood cultures obtained during hospitalization showed no growth. She did not improve with the initial antimicrobial regimen, and clindamycin was added. Gram's staining of sputum revealed 4+ (i.e., abundant) polymorphonuclear cells, 3+ gram-positive cocci in pairs and clusters, and 3+ gram-negative rods but more than 10 epithelial cells. Staining for acidfast bacillus was negative on three sputum specimens, as was fungal staining and staining with toluidine blue O for P. jiroveci. Urine testing for legionella, histoplasma, and blastomyces antigens and serum testing for cryptococcal antigen were negative. A CT of the chest showed dense consolidation in the left upper lobe without lymphadenopathy (Fig. 2) .
Bacterial infections with organisms such as Staphylococcus aureus, Hemophilus influenzae, or anaerobes may cause chronic pneumonia. The presence of bacteria on Gram's staining of sputum in this patient, however, is not sufficient evidence to make a diagnosis of bacterial pneumonia. Because of her immunosuppressed state and history of cancer, I favor more-invasive diagnostic testing. Quantitative or protected-specimen-brushing cultures may be helpful, although the fact that she has been treated with antibiotics increases the likelihood that these will be negative even if bacterial infection is present. Failure to grow mycobacteria or nocardia from bronchoalveolar-lavage fluid would make these diagnoses unlikely. P. jiroveci could be ruled out by negative results of monoclonal-antibody staining or polymerase chain reaction of bronchoalveolar-lavage fluid.
Several days after admission, repeated chest radiography showed worsening disease, and bronchoscopy was planned. Before the procedure was performed, however, Gram's staining of a second sputum specimen revealed beaded, branching, gram-positive rods (Fig. 3) .
In an immunosuppressed patient with a chronic lobar infiltrate and branching, gram-positive rods in the sputum, infection caused by nocardia is the most likely diagnosis. Actinomycosis, however, has a similar appearance; on rare occasions, acid-fast bacilli may also appear as branching, gram-positive rods. The diagnosis can be confirmed in this case, since nocardia will generally grow on mediums routinely used in clinical microbiology laboratories. The patient's nature photography and time spent in the woods may have exposed her to nocardia. I would begin treatment with trimethoprim-sulfamethoxazole and defer bronchoscopy pending confirmatory results of a culture.
Culture 2 days later grew Nocardia nova. The patient was given intravenous trimethoprim-sulfamethoxazole when results of the culture became available. She responded to this regimen and was discharged from the hospital with a planned 6-month course of therapy with oral trimethoprimsulfamethoxazole. At a follow-up visit 2 months after beginning treatment with trimethoprim-sulfamethoxazole, the patient was symptomatically much improved, with minimal cough and no shortness of breath. She had an erythrocyte sedimentation rate of 20 mm per hour and had marked improvement on her chest CT.
C om men ta r y
Correctly and efficiently diagnosing the cause of pulmonary disease in an immunocompromised patient is challenging. Knowledge of the rate of disease progression and the type of immune compromise is useful in the initial differential diagnosis. A detailed history to elicit epidemiologic exposures further refines the possible diagnoses. Finally, the pattern of lung involvement (i.e., lobar, interstitial, or alveolar) can also help narrow down the possible causes. In the case of this patient, the tempo of illness suggested chronic pneumonia, and that, coupled with the fact that the patient was receiving corticosteroids, which compromised her cellular immunity, led to early suspicion of nocardia as a potential cause of her symptoms. Her travel and outdoor photography increased our suspicion of nocardiosis, as did the focal abnormalities on chest imaging.
A widely used model of the diagnostic process and analytic reasoning is the "hypotheticodeductive" method, where hypotheses are proposed, tested, and verified or rejected. 1 Clinicians have detailed mental catalogues of disease states -"illness scripts" -that combine knowledge with clinical experience and are useful as templates to compare clinical information from a particular patient. 2 Our discussant used a combination of pattern recognition (productive cough and dyspnea for 1 month in an immunocompromised patient) and analytic reasoning (using additional information to evaluate differential diagnoses and modify the illness script) to arrive at the correct answer.
Nocardia species are ubiquitous in the environment but are not common causes of illness; an estimated 500 to 1000 cases of infection from nocardia occur every year in the United States. 3 Inhalation is the most common route of infection, and the lung is the most frequently involved organ. 4 The organism has a predilection for the central nervous system, 5 and central nervous system involvement should be assessed by physical examination. Imaging is indicated if the examination suggests involvement of the central nervous system. Localized cutaneous disease caused by direct inoculation of the organism into the skin, as well as disseminated disease and bacteremia in association with central venous catheters, have been well described. 6 N. asteroides is the cause in approximately 80 to 90% of cases of nocardiosis; the next most common are N. brasiliensis, N. farcinia, N. nova, and N. transvalensis. 4 Although one third of patients with nocardiosis are immunocompetent, nocardiosis typically is regarded as an opportunistic infection. 7 Cell-mediated immunity is crucial to containing the infection, and a variety of immune-compromising conditions -organ transplantation, cancer, diabetes mellitus, alcoholism, acquired immune deficiency syndrome, and long-term use of corticosteroids -have been reported to increase risk. 8 Nocardia are gram-positive, aerobic bacteria, which may appear in tissue sections as branching, beaded rods. 9 Examination of Gram's staining of a sputum sample is often useful for diagnosing nocardia; in a series of 20 patients, nocardia was seen on Gram's staining in 68% of sputum samples. 10 Actinomyces may resemble nocardia on the Gram's-stained sample. Although not acid-fast by the standard Ziehl-Neelsen staining method used for mycobacteria, nocardiae may be seen with the use of the modified acid-fast stain (using a gentler organic acid as the decolorizing agent). The definitive diagnosis of nocardial disease requires demonstration of the organism on culture from a suspected site. 11 Nocardiae typically appear within 2 to 7 days on most routine bacteriologic mediums, such as 5% sheep's-blood agar, chocolate agar, and blood-culture broth mediums (Bactec, Becton Dickinson). 9 Recommended antimicrobial therapy for nocardiosis is based on case series, investigations in animal models, and profiles of in vitro antimicrobial activity. 12 Sulfonamides have been considered the standard of therapy for the past four decades. 12,13 Although all seem to be equally efficacious, trimethoprim-sulfamethoxazole is used most frequently. Susceptibility testing should be performed, particularly in refractory cases. Alternatives to sulfonamides include minocycline, amikacin, imipenem, and linezolid. 14,15 The optimal duration of therapy is uncertain, but because of a high risk of relapse, treatment is generally given for 6 to 12 months, depending on the severity of the disease.
Our patient was maintained on a higher-thanusual dose of prednisone and additional immunosuppressive treatment for presumed giant-cell arteritis because of refractory symptoms. Continued vigilance and a high index of suspicion for infection must be maintained in all patients receiving immunosuppressive therapy, and efforts should be made to taper medication as early as the disease permits. The consideration of pneumocystis as the possible cause of the patient's pulmonary disease underscores the need to consider prophylaxis against this organism in patients whose cell-mediated immunity is compromised. If at the end of therapy for nocardia, the patient still requires immunosuppressive therapy, prophylaxis with trimethoprim-sulfamethoxazole should be given. 
